FDA Clearance Tracker · K210629
SecurAcath
Last checked: Nov 19, 2026Latest source record: Apr 12, 2021 (this decision)Source: openFDAMethods & limitations
Decided
Apr 12, 2021
Substantially Equivalent
Time to decision
41 days
Received Mar 2, 2021. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K210629
- Device name
- SecurAcath
- Applicant
- Interrad Medical, Inc.
- Applicant location
- Plymouth, MN
- Received
- Mar 2, 2021
- Decided
- Apr 12, 2021
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device class
- Class II
- Regulation
- 21 CFR 880.5970
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code OKC. The earliest in FDA's data is K082047, decided Sep 30, 2008.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K210629
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Interrad Medical, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K180994 · Decided Jul 9, 2019 · 449 days after receipt
Device type: Device, Intravascular Catheter Securement (KMK) · Hospital Medicine & Nursing
- SecurAcath510(k)
K180769 · Decided Jun 26, 2018 · 95 days after receipt
Device type: Implanted Subcutaneous Securement Catheter (OKC) · Hospital Medicine & Nursing
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.